Clinical Trial Update: A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GK Activator (2) in patients with Type 2 diabetes mellitus on a stable dose of metformin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GK Activator (2)
• metformin (metformin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED